EAST HANOVER, N.J., Oct. 8, 2019 /PRNewswire/ -- Novartis is inviting patient advocacy organizations to submit proposals for programs that offer to expand and improve understanding of biomarker ...

Advarra, Virb and BeeKeeperAI sign on to Beacon of Hope to provide suite of digital tools to facilitate clinical trials and research on healthcare inequities at Historically Black Medical School ...

Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s ...

EAST HANOVER, N.J., July 11, 2019 /PRNewswire/ -- The Know Now Testing Program, a Novartis initiative in collaboration with Quest Diagnostics, offers genetic mutation testing at no cost for all ...

(Thomson Reuters ONE via COMTEX) -- Novartis International AG / Novartis vaccine Bexsero(R) sees high uptake in first large-scale public vaccination program to help protect against devastating ...

Company also gained rights to first negotiation for a preclinical RSV program. Novartis paid AlphaVax $20 million for an exclusive license to its early-stage cytomegalovirus (CMV) vaccine program. The ...

Novartis’ fevipiprant has failed another pair of phase 3 clinical trials, prompting the Swiss pharma to halt further development of the DP2 antagonist in asthma. The setback means Amgen, AstraZeneca ...

PTC Therapeutics signed a $1billion upfront deal with Novartis for its Huntington's program, with potential milestones of $1.9 billion. Interim Phase 2 data shows PTC518 reduces mutant protein levels ...

Novartis Pharmaceuticals Corp. on Wednesday became the second company to launch a prescription discount program for low-income elderly Americans, but analysts said it would not lower costs enough for ...

A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug Price Negotiation Program, ruling that the program does not violate ...

The court ruled that Novartis is not legally compelled to participate in the Medicare Drug Price Negotiation Program. The decision reaffirmed that the program does not constitute excessive fines, ...